Crinetics Pharmaceuticals (CRNX) Cash & Equivalents (2017 - 2026)
Crinetics Pharmaceuticals' Cash & Equivalents was $55.5 million in Q2 2026, up 3.3% from $53.73 million a year earlier but down 51.5% from the prior quarter.
Powered by 
Analysis
Crinetics Pharmaceuticals (CRNX) Cash & Equivalents (2017 - 2026) Analysis & Trends
At the end of FY2025, Cash & Equivalents at Crinetics Pharmaceuticals came in at $101.54 million, down 61.6% from FY2024.
- Cash & Equivalents shows a five-year compound annual growth rate of 1.8% (FY2020 to FY2025).
- In earlier years, Cash & Equivalents was $264.55 million in FY2024 (+381.9%), $54.9 million in FY2023 (+61.6%), $33.97 million in FY2022 (-83.1%) and $201.2 million in FY2021 (+116.1%).
- Quarterly Cash & Equivalents has moved between $30.91 million (Q3 2022) and $395.92 million (Q1 2024) over five years.
- Compared with a year earlier, Cash & Equivalents was higher in four of the last eight quarters, with growth averaging 30.4%.
- The best year-over-year quarter for Cash & Equivalents over five years was Q1 2024 (growth of 861.1%); the worst was Q4 2022 (a decline of 83.1%).
- Per Business Quant data, CRNX's Cash & Equivalents in the three quarters before Q2 2026 was $114.34 million (Q1 2026), $101.54 million (Q4 2025) and $110.9 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Crinetics Pharmaceuticals | 8.99 Bn | 8.99 Bn | 24.96 Mn | 55.50 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 55.50 Mn |
| Mar 31, 2026 | 114.34 Mn |
| Dec 31, 2025 | 101.54 Mn |
| Sep 30, 2025 | 110.90 Mn |
| Jun 30, 2025 | 53.73 Mn |
| Mar 31, 2025 | 94.57 Mn |
| Dec 31, 2024 | 264.55 Mn |
| Sep 30, 2024 | 317.27 Mn |
| Jun 30, 2024 | 302.16 Mn |
| Mar 31, 2024 | 395.92 Mn |
| Dec 31, 2023 | 54.90 Mn |
| Sep 30, 2023 | 142.80 Mn |
| Jun 30, 2023 | 39.55 Mn |
| Mar 31, 2023 | 41.19 Mn |
| Dec 31, 2022 | 33.97 Mn |
| Sep 30, 2022 | 30.91 Mn |
| Jun 30, 2022 | 62.29 Mn |
| Mar 31, 2022 | 145.55 Mn |
| Dec 31, 2021 | 201.20 Mn |
| Sep 30, 2021 | 161.54 Mn |
API Access
Crinetics Pharmaceuticals Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=CRNX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "CRNX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=CRNX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();